Clinical trial
Treatment of Acute Myeloblastic Leukemia in Younger Patients
NCT00390715 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00390715 |
|---|---|
| Title | Treatment of Acute Myeloblastic Leukemia in Younger Patients |
| Official title | Prospective Study of the Value of the Cytogenetic and of the Monitoring of the Minimal Residual Disease |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Acute Myeloblastic Leukemia |
| Intervention type | Drug |
| Interventions | chemotherapy |
| Enrollment | 600 |
| Start date | Jan 1, 1999 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2010 |
| First posted | Oct 20, 2006 |
| Last update posted | Mar 15, 2010 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: